Thick melanoma is associated with low melanoma knowledge and low perceived health competence, but not delays in care - 23/07/20
Doi : 10.1016/j.jaad.2019.05.068
Sophia H. Zhang, BS a, Rebecca Liu, BS a, Nalyn Siripong, PhD b, John M. Kirkwood, MD c, Matthew P. Holtzman, MD c, Diwakar Davar, MD c, Yana Najjar, MD c, Keely Marshall, MD, PhD d, Stephanie R. Jackson Cullison, MD, PhD d, Neil A. Houston, MD e, Galen Switzer, PhD f, g, Laura K. Ferris, MD, PhD d, ⁎ 
a University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
b Clinical & Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
c UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
d Department of Dermatology, University of Pittsburgh, Pittsburgh, Pennsylvania
e Department of Dermatology, University of Colorado, Aurora
f Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
g Center for Health Equity Research and Promotion, VA Pittsburgh Health Care System
∗Correspondence to: Laura K. Ferris, MD, PhD, University of Pittsburgh, Dermatology, 3708 Fifth Ave, Pittsburgh, PA 15213University of PittsburghDermatology3708 Fifth AvePittsburghPA15213
| Funding sources: Supported in part by the National Institutes of Health (grant UL1-TR-001857). |
|
| Disclosure: Dr Ferris is a consultant for DermTech International and an investigator for Castle Biosciences. Dr Davar is an advisory board member for Merck, Immunocore, and Incyte and an investigator for Bristol-Myers Squibb, CheckMate Pharmaceuticals, and Tesaro. Dr Kirkwood is a consultant for Array Biopharma, BMS, Novartis, Roche, Immunocore, Merck, and Amgen and an investigator for Prometheus. Dr Najjar is an advisory board member for Array BioPharma and an investigator for Merck. Ms Zhang, Ms Liu, Dr Siripong, Dr Holtzman, Dr Marshall, MD, Dr Cullison, Dr Houston, and Dr Switzer have no conflicts to disclose. |
|
| IRB approval status: Approved by University of Pittsburgh IRB #PRO17010289. |
|
| Presented as an E-poster at the 2019 American Academy of Dermatology Annual Meeting, Washington, DC, March 1-5, 2019, and the 51st Annual Meeting of the Pennsylvania Academy of Dermatology, September 14-16, 2018, Poconos, Pennsylvania. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 2
P. 587-590 - août 2020 Retour au numéro
Article précédent
- Hydroxychloroquine effects on psoriasis: A systematic review and a cautionary note for COVID-19 treatment
- Muskaan Sachdeva, Asfandyar Mufti, Khalad Maliyar, Yuliya Lytvyn, Jensen Yeung
- Evaluation of a virtual basic dermatology curriculum for dermoscopy by using the triage amalgamated dermoscopic algorithm for novice dermoscopists
- Jason R. Susong, Hadjh T. Ahrns, Andrew Daugherty, Ashfaq A. Marghoob, Elizabeth V. Seiverling
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?